Multivariate analysis of prognostic variables for disease-free and overall survival
Variable . | Disease-free survival . | . | . | . | Overall survival . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | β . | SE . | HR (95% CI) . | P . | β . | SE . | HR (95% CI) . | P . | ||||||
Tumor differentiation | ||||||||||||||
G1–G2/G3 | 0.80 | 0.52 | 0.45 (1.23–0.16) | 0.12 | 0.78 | 0.51 | 0.46 (1.25–0.17) | 0.13 | ||||||
Histological type | ||||||||||||||
SCCa/non-SCC | 0.42 | 0.42 | 0.66 (1.50–0.29) | 0.32 | 0.36 | 0.42 | 0.70 (1.58–0.31) | 0.32 | ||||||
Tumor size | ||||||||||||||
T1/T2 | 0.63 | 0.51 | 0.53 (1.46–0.20) | 0.22 | 0.66 | 0.51 | 0.52 (1.41–0.19) | 0.20 | ||||||
90K expression | ||||||||||||||
Low/high | 1.70 | 0.43 | 5.50 (12.87–2.34) | 0.0003 | 1.62 | 0.43 | 5.04 (11.72–2.16) | 0.0005 |
Variable . | Disease-free survival . | . | . | . | Overall survival . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | β . | SE . | HR (95% CI) . | P . | β . | SE . | HR (95% CI) . | P . | ||||||
Tumor differentiation | ||||||||||||||
G1–G2/G3 | 0.80 | 0.52 | 0.45 (1.23–0.16) | 0.12 | 0.78 | 0.51 | 0.46 (1.25–0.17) | 0.13 | ||||||
Histological type | ||||||||||||||
SCCa/non-SCC | 0.42 | 0.42 | 0.66 (1.50–0.29) | 0.32 | 0.36 | 0.42 | 0.70 (1.58–0.31) | 0.32 | ||||||
Tumor size | ||||||||||||||
T1/T2 | 0.63 | 0.51 | 0.53 (1.46–0.20) | 0.22 | 0.66 | 0.51 | 0.52 (1.41–0.19) | 0.20 | ||||||
90K expression | ||||||||||||||
Low/high | 1.70 | 0.43 | 5.50 (12.87–2.34) | 0.0003 | 1.62 | 0.43 | 5.04 (11.72–2.16) | 0.0005 |
SE, standard error; HR, Hodds ratio; CI, confidence interval; SCC, squamous cell carcinoma.